 Shares of Motus GI Hldgs NASDAQ: MOTS were flat after the company reported Q2 results. Quarterly Results Earnings per share increased 42.31 year over year to 0.15, which beat the estimate of 0.21. Revenue ofShares of Motus GI Hldgs NASDAQ:MOTS decreased 4.8 after the company reported Q2 results.Quarterly Results Earnings per share increased 42.31 year over year to 0.15, which beat the estimate of 0.21.Revenue of 1,000 decreased by 75.00 from the same period last year, which missed the estimate of 20,000.Outlook Motus GI Hldgs hasnt issued any earnings guidance for the time being.Motus GI Hldgs hasnt issued any revenue guidance for the time being.Conference Call Details Date: Aug 11, 2020View more earnings on MOTSTime: 04:30 PMET Webcast URL: Stock Performance 52-week high: 2.9952-week low: 0.46Price action over last quarter: Up 12.26Company Description Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The company is focused on the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.See more from Benzinga Earnings Scheduled For August 11, 2020C 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 